These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26527951)

  • 1. Inflammatory markers in paroxysmal atrial fibrillation and the protective role of renin-angiotensin-aldosterone system inhibitors.
    Roşianu ŞH; Roşianu AN; Aldica M; Căpâlneanu R; Buzoianu AD
    Clujul Med; 2013; 86(3):217-21. PubMed ID: 26527951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin system inhibition is associated with reduced risk of left atrial appendage thrombosis formation in patients with atrial fibrillation.
    Suo Y; Zhang Y; Wang Y; Yuan M; Kariyawasam S; Tse G; Liu T; Fu H; Li G
    Cardiol J; 2018; 25(5):611-620. PubMed ID: 28980280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin-aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy.
    Huang CY; Yang YH; Lin LY; Tsai CT; Hwang JJ; Chen PC; Lin JL
    Heart; 2018 Aug; 104(15):1276-1283. PubMed ID: 29371376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Chaugai S; Meng WY; Ali Sepehry A
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):388-404. PubMed ID: 26817632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.
    Ozaydin M; Varol E; Türker Y; Peker O; Erdoğan D; Doğan A; Ibrişim E
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):137-42. PubMed ID: 20382613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial.
    Goette A; Schön N; Kirchhof P; Breithardt G; Fetsch T; Häusler KG; Klein HU; Steinbeck G; Wegscheider K; Meinertz T
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):43-51. PubMed ID: 22157519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation.
    Watanabe T; Takeishi Y; Hirono O; Itoh M; Matsui M; Nakamura K; Tamada Y; Kubota I
    Heart Vessels; 2005 Mar; 20(2):45-9. PubMed ID: 15772777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure.
    Shi Y; Li D; Tardif JC; Nattel S
    Cardiovasc Res; 2002 May; 54(2):456-61. PubMed ID: 12062350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of plasma fibronectin level with left atrial electrical and structural remodelling in lone paroxysmal atrial fibrillation: a cross-sectional study].
    Canpolat U; Oto A; Yorgun H; Sunman H; Şahiner L; Kaya EB; Özer N; Aytemir K
    Turk Kardiyol Dern Ars; 2015 Apr; 43(3):259-68. PubMed ID: 25905997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
    Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions Among Vitamin D, Atrial Fibrillation, and the Renin-Angiotensin-Aldosterone System.
    Turin A; Bax JJ; Doukas D; Joyce C; Lopez JJ; Mathew V; Pontone G; Shah F; Singh S; Wilber DJ; Rabbat MG
    Am J Cardiol; 2018 Sep; 122(5):780-784. PubMed ID: 30057228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials.
    Khatib R; Joseph P; Briel M; Yusuf S; Healey J
    Int J Cardiol; 2013 Apr; 165(1):17-24. PubMed ID: 22421406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating and local renin-angiotensin-aldosterone system express differently in atrial fibrillation patients with different types of mitral valvular disease.
    Qian Y; Liu Y; Tang H; Zhou W; Jiang L; Li Y; Li N; Li M; Xiao X
    J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):204-11. PubMed ID: 23077077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between inflammatory markers and clinical patterns of atrial fibrillation in patients with congestive heart failure.
    Targoński R; Salczyńska D; Sadowski J; Cichowski L
    Kardiol Pol; 2008 Jul; 66(7):729-36; discussion 737-9. PubMed ID: 18690564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role Of Renin Angiotensin System In Atrial Fibrillation.
    Nair GM; Nery PB; Redpath CJ; Birnie DH
    J Atr Fibrillation; 2014; 6(6):972. PubMed ID: 27957054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the elevated uric acid levels and circulating renin-angiotensin-aldosterone system activation in patients with atrial fibrillation.
    Wang XD; Liu J; Zhang YC; Wang Y; Wang Y; Ma D
    Cardiovasc Diagn Ther; 2021 Feb; 11(1):50-55. PubMed ID: 33708477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is atrial fibrillation an inflammatory disorder?
    Boos CJ; Anderson RA; Lip GY
    Eur Heart J; 2006 Jan; 27(2):136-49. PubMed ID: 16278230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between vitamin D level and left atrial fibrosis in patients with lone paroxysmal atrial fibrillation undergoing cryoballoon-based catheter ablation.
    Canpolat U; Aytemir K; Hazirolan T; Özer N; Oto A
    J Cardiol; 2017 Jan; 69(1):16-23. PubMed ID: 27554047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.